Everything we do is
backed by science
OUR BEGINNINGS
Focused on Alzheimer's from day one
Neurotrack was co-founded in 2012 by Elli Kaplan, Elizabeth Buffalo, Ph.D., Cecelia Manzanares, and cognitive impairment testing pioneer Stuart Zola, Ph.D.
- Collectively, our co-founders and clinical team members have authored 354 peer-reviewed papers
- Their research has been cited more than 37,000 times
- They've made notable contributions in the study of Alzheimer's, memory, and cognitive neuroscience
Dr. Stuart Zola
- Introduced digital phenotyping for early detection of cognitive decline
- Shaped our understanding of how memory is organized in the brain
- Leadership roles at UCSD, Atlanta VA Medical Center, and Emory University
To date, Neurotrack has received $4.3 million in grants from the National Institute on Aging, Alzheimer’s Drug Discovery Foundation, and the Georgia Research Alliance
OUR RESEARCH PARTNERS
Scientific accomplishments by the numbers
25
CORE COMPANY STUDIES PUBLISHED
11
PATENTS ON OUR TECHNOLOGY
40+
USER INTERVIEWS & FIELD WORK EVENTS EACH YEAR
100+
YEARS OF RESEARCH BEHIND OUR TESTS
OUR BREAKTHROUGHS
Research highlights
Explore key insights from our publications or browse the full list below.
Alzheimer's Disease & Other Dementias
Computerized task predicts MCI and Alzheimer’s disease
Frontiers in Aging Neuroscience
Neurotrack assessment delivers high sensitivity & specificity
JMIR Aging
Validation study: Neurotrack’s screening meets gold standard measures
Journal of Prevention of Alzheimer's Disease
Neurotrack spots distraction signals in remote testing
JMIR Formative Research
Neurotrack digital tests are reliable for repeat use
Geroscience
Neurotrack’s brain health education boosts outcomes
